THE global leader in  blood management solutions for our customers

2019 Press Releases

Webcast ImageWebcast
Q1 2020 Haemonetics Corporation Earnings Conference Call  (Live)
08/06/19 at 8:00 a.m. ET
Q1 2020 Haemonetics Corporation Earnings Conference Call
Tuesday, August 6, 2019 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle 
Jun. 26, 2019Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2020 Results: August 6, 2019
BRAINTREE, Mass., June 26, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish first quarter fiscal year 2020 financial results at 6:00 am EDT on Tuesday, August 6, 2019. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on August 6, 2019.  The call can be accessed with the following information: U.S. / Canada toll free (877) 848-8880; In... 
Printer Friendly Version
May. 14, 2019Haemonetics To Transfer Union, South Carolina, Manufacturing Facility To CSL Plasma Inc.
BRAINTREE, Mass. and BOCA RATON, Fla., May 14, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) and CSL Plasma Inc. today announced an agreement to transfer ownership of Haemonetics' Union, South Carolina, manufacturing facility, operating assets and certain inventories to CSL Plasma. The facility produces liquid saline and sodium citrate, which are solutions used in the plasmapheresis, or plasma collection, process. CSL Plasma provides plasma to global biotechnology leader CSL Behring a... 
Printer Friendly Version
May. 13, 2019Haemonetics Receives FDA Clearance For Expanded Use Of TEG® 6s Hemostasis Analyzer System In Adult Trauma Settings
BRAINTREE, Mass., May 13, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the medical indication of its TEG® 6s Hemostasis Analyzer System for use in adult trauma settings. This clearance builds on the current indication for the TEG 6s system in cardiovascu... 
Printer Friendly Version
May. 07, 2019Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website
Financial release accessible online BRAINTREE, Mass., May 7, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its fourth quarter and fiscal year ended March 30, 2019 are available on its Investor relations website. The Company is posting the earnings release and results tables that will be referenced on its webcast to its Investor Relations website.  Direct link to Earnings Release 4Q and FY19: http://phx.cor... 
Printer Friendly Version
Apr. 29, 2019Claire Pomeroy Joins Haemonetics Board of Directors
BRAINTREE, Mass., April 29, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the election of Claire Pomeroy, M.D., MBA, to its Board of Directors. Dr. Pomeroy is President of the Albert and Mary Lasker Foundation and serves as Chief Executive Officer, responsible for advancing the Foundation's mission to improve health by accelerating support for medical research through recognition of research excellence, education and advocacy. Dr. Pomeroy... 
Printer Friendly Version
Mar. 25, 2019Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2019 Results: May 7, 2019
BRAINTREE, Mass., March 25, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and full fiscal year 2019 financial results at 6:00 am ET on Tuesday, May 7, 2019. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 7, 2019.  The call can be accessed with the following information: U.S. / Canada toll free (877) 848-8880... 
Printer Friendly Version
Feb. 05, 2019Haemonetics 3rd Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website
Financial release accessible online BRAINTREE, Mass., Feb. 5, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that its third quarter and year-to-date fiscal 2019 results ended December 29, 2018 are available on its Investor relations website. The Company is posting the earnings release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.  Direct link to Earnings Release 3Q and YTD ... 
Printer Friendly Version